Zobrazeno 1 - 10
of 727
pro vyhledávání: '"smoldering multiple myeloma"'
Autor:
Abe T; Department of Nephrology, Kitasato University School of Medicine., Wada Y; Department of Nephrology, Kitasato University School of Medicine., Takeuchi K; Department of Nephrology, Kitasato University School of Medicine.; Department of Analytic Human Pathology, Nippon Medical School., Uchitsubo R; Department of Nephrology, Kitasato University School of Medicine., Sakurabayashi S; Department of Nephrology, Kitasato University School of Medicine., Kawamura S; Department of Nephrology, Kitasato University School of Medicine., Kamata M; Department of Nephrology, Kitasato University School of Medicine.; Department of Pharmacology, Kitasato University School of Medicine., Naito S; Department of Nephrology, Kitasato University School of Medicine., Aoyama T; Department of Nephrology, Kitasato University School of Medicine., Shimizu A; Department of Analytic Human Pathology, Nippon Medical School., Takeuchi Y; Department of Nephrology, Kitasato University School of Medicine.
Publikováno v:
The Tohoku journal of experimental medicine [Tohoku J Exp Med] 2024 Nov 16; Vol. 264 (1), pp. 53-60. Date of Electronic Publication: 2024 Jun 20.
Autor:
Mouhieddine TH; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, 1 Gustave L. Levy Place, Box 1079, New York, NY, 10029, USA. tarek.mouhieddine@mountsinai.org.
Publikováno v:
Current oncology reports [Curr Oncol Rep] 2024 Nov; Vol. 26 (11), pp. 1398-1409. Date of Electronic Publication: 2024 Aug 23.
Autor:
Rajkumar SV; Mayo Clinic, Rochester, MN, USA., Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain., Schaeffer M; Janssen Pharmaceutica NV, Beerse, Belgium., Lin X; Janssen Global Services, Horsham, PA, USA., Bathija S; Janssen Global Services, Raritan, NJ, USA., Gupta-Werner N; Janssen Scientific Affairs, Horsham, PA, USA., Lam A; Janssen Global Services, Raritan, NJ, USA., Carson R; Janssen Research & Development, Wayne, PA, USA., Dennis R; Janssen Research & Development, Wayne, PA, USA., Kaila S; Janssen Scientific Affairs, Horsham, PA, USA., Matt K; Janssen Global Services, Raritan, NJ, USA., Duran J; Janssen Global Services, Raritan, NJ, USA., Lonial S; Emory University School of Medicine, Atlanta, GA, USA. sloni01@emory.edu.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Dec 05; Vol. 14 (1), pp. 215. Date of Electronic Publication: 2024 Dec 05.
Autor:
Puig N; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., Agulló C; Biochemistry Department, University Hospital of Salamanca, Salamanca., Contreras T; Biochemistry Department, University Hospital of Salamanca, Salamanca., Pérez JJ; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., Aires I; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., Calasanz MJ; Hematology Department, Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona., García-Sanz R; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., Castro S; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., Martínez-López J; Hematology Department, Hospital 12 de Octubre, Medicine Department, Medicine School of Complutense University, I+12. CNIO, Madrid., Rodríguez-Otero P; Hematology Department, Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona., González-Calle V; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., González MS; Hematology Department, Hospital Clínico Universitario Santiago de Compostela, Santiago de Compostela., Oriol A; Clinical Hematology, Institut Català d'Oncologia and Josep Carreras Research Institute, Hospital Germans Trias I Pujol, Badalona., Gutiérrez NC; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca., Ríos-Tamayo R; Unidad de Gammapatías Monoclonales. Hospital Universitario Puerta de Hierro, Majadahonda., Rosiñol L; Hematology Department, Hospital Clinic, IDIBARS, Barcelona., Álvarez MÁ; Hematology Department, Hospital Universitario Reina Sofía, Córdoba., Bargay J; Hematology Department, Hospital Universitario Son Llatzer, IdISBa (Institut d'Investigació Sanitaria Illes Balears), Palma., González-Rodríguez AP; Hematology Department, Hospital Universitario Central de Asturias, Oviedo., Alegre A; University Hospital La Princesa and University Hospital QuironSalud, Autónoma University, Madrid., Escalante F; Servicio de Hematología, Unidad i+i, Complejo Asistencial Universitario de León, León., Iñigo MB; Hematology Department, Hospital Clínico San Carlos, Madrid., De la Rubia J; Hematology Department, Hospital Universitario y Politécnico La Fe, Universidad Católica de Valencia, CIBERONC, Valencia., Teruel AI; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia., De Arriba F; Hematology Department, Hospital Universitario Morales Meseguer, IMIBPascual., Palomera L; Hematology Department, Hospital Clínico Universitario Lozano Blesa, Instituto de Investigación Sanitaria de Aragón, Zaragoza., Hernández MT; Hematology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife., López-Jiménez J; Hematology Department, Hospital Ramón y Cajal, Madrid., Reinoso M; Hematology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS) / CSIC, Universidad de Sevilla, Sevilla., García-Mateo A; Hematology Department, Complejo Asistencial de Segovia, Segovia., Ocio EM; Hematology Department, Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander., Bladé J; Hematology Department, Hospital Clinic, IDIBARS, Barcelona., Lahuerta JJ; Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid., Cedena MT; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid., Paiva B; Hematology Department, Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona., Miguel JFS; Hematology Department, Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona., Mateos MV; Hematology Department, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer, IBMCC (USAL-CSIC), Salamanca. mvmateos@usal.es.
Publikováno v:
Haematologica [Haematologica] 2024 Dec 01; Vol. 109 (12), pp. 4056-4066. Date of Electronic Publication: 2024 Dec 01.
Autor:
Weinhold N; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Rasche L; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.; Mildred Scheel Early Career Center, Universitätsklinikum Würzburg, Würzburg, Germany.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 01; Vol. 30 (19), pp. 4263-4265.
Autor:
Schmidt T; Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison WI., Gahvari Z; Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison WI., Callander NS; Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison WI. Electronic address: nsc@medicine.wisc.edu.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Oct; Vol. 24 (10), pp. 653-664. Date of Electronic Publication: 2024 Mar 16.
Autor:
Kazandjian D; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.; Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Diamond B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Papadimitriou M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Hill E; Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Sklavenitis-Pistofidis R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Ziccheddu B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Blaney P; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Chojnacka M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Durante M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Maclachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Young R; Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Usmani S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Davies F; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Getz G; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Ghobrial I; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Korde N; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Morgan G; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York., Maura F; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Landgren O; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 01; Vol. 30 (19), pp. 4482-4490.
Autor:
Werly A; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Hampel M; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zuern K; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Schmidt SK; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Visram A; Division of Haematology, The Ottawa Hospital, Ottawa, Canada., Raab MS; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Mueller-Tidow C; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Goldschmidt H; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Mai EK; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany. elias.mai@med.uni-heidelberg.de.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Oct 14; Vol. 14 (1), pp. 176. Date of Electronic Publication: 2024 Oct 14.
Autor:
Sharma D; Department of Dermatology, Icahn School of Medicine at Mount Sinai, 5 East 98th Street, New York, NY, 10029, USA., Ungar B; Department of Dermatology, Icahn School of Medicine at Mount Sinai, 5 East 98th Street, New York, NY, 10029, USA., Adalsteinsson JA; Department of Dermatology, Icahn School of Medicine at Mount Sinai, 5 East 98th Street, New York, NY, 10029, USA. jonas.adalsteinsson@mountsinai.org., Sigurdsson JK; University of Iceland, Reykjavik, Iceland., Sharp K; Frank H. Netter MD School of Medicine, Quinnipiac University, North Haven, USA., Thorsteinsdóttir S; University of Iceland, Reykjavik, Iceland.; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Rögnvaldsson S; University of Iceland, Reykjavik, Iceland.; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Þórðardóttir ÁR; University of Iceland, Reykjavik, Iceland., Viðarsson B; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Önundarson PT; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Agnarssond BA; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Sigurðardóttird M; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Þorsteinsdóttir I; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Ólafsson Í; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Eyþórsson E; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Jónsson Á; Akureyri Hospital, Akureyri, Iceland., Ólafsson A; University of Iceland, Reykjavik, Iceland., Gíslason GK; University of Iceland, Reykjavik, Iceland., Landgren O; Myeloma Program, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA., Hulcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Durie BG; Cedars-Sinai Outpatient Cancer Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA., Harding S; Binding Site Group Ltd, Birmingham, UK., Love TJ; University of Iceland, Reykjavik, Iceland.; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland., Kristinsson SY; University of Iceland, Reykjavik, Iceland.; The National University Hospital of Iceland, Landspitali, Reykjavik, Iceland.
Publikováno v:
Archives of dermatological research [Arch Dermatol Res] 2024 Sep 14; Vol. 316 (9), pp. 627. Date of Electronic Publication: 2024 Sep 14.
Autor:
Kumar S; The Mayo Clinic, Rochester, MN, USA., Rajkumar SV; The Mayo Clinic, Rochester, MN, USA., Jevremovic D; The Mayo Clinic, Rochester, MN, USA., Kyle RA; The Mayo Clinic, Rochester, MN, USA., Shifrin Y; Telo Genomics Corp, Toronto, Ontario, Canada., Nguyen M; Telo Genomics Corp, Toronto, Ontario, Canada., Husain Z; Telo Genomics Corp, Toronto, Ontario, Canada., Alikhah A; Telo Genomics Corp, Toronto, Ontario, Canada., Jafari A; Telo Genomics Corp, Toronto, Ontario, Canada., Mai S; University of Manitoba, Winnipeg, Manitoba, Canada., Anderson K; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Louis S; Telo Genomics Corp, Toronto, Ontario, Canada.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Aug; Vol. 99 (8), pp. 1532-1539. Date of Electronic Publication: 2024 May 15.